Bulletin
Investor Alert

Sorrento Therapeutics Inc.

NAS: SRNE

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Feb 3, 2023, 7:58 p.m.

/zigman2/quotes/205669265/composite

$

1.03

Change

+0.01 +0.98%

Volume

Volume 223,938

Quotes are delayed by 20 min

/zigman2/quotes/205669265/composite

Today's close

$ 1.02

$ 1.02

Change

0.00 0.00%

Day low

Day high

$0.98

$1.06

Open

52 week low

52 week high

$0.74

$3.60

Open

Company Description

Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular the...

Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. It operates through the Sorrento Therapeutics and Scilex segments. The company was founded by Henry H. Ji in 1989 and is headquartered in San Diego, CA.

Valuation

Price to Sales Ratio

25.91

Price to Book Ratio

18.58

Enterprise Value to EBITDA

-1.68

Enterprise Value to Sales

9.81

Efficiency

Total Asset Turnover

0.08

Liquidity

Current Ratio

1.24

Quick Ratio

1.18

Cash Ratio

0.91

Profitability

Gross Margin

67.54

Operating Margin

-695.68

Pretax Margin

-874.28

Net Margin

-809.63

Return on Assets

-62.45

Return on Equity

-351.23

Return on Total Capital

-117.62

Capital Structure

Total Debt to Total Assets

30.74

Officers and Executives

Name Age Officer Since Title
Dr. Henry H. Ji 57 2006 President, Chief Executive Officer & Director
Dr. Shawn Sahebi - - Senior Vice President-Strategy & Analytics
Ms. Elizabeth Adkins Czerepak 65 2021 Independent Director
Dr. Robert D. Allen - - Senior Vice President-Research & Development
Dr. Mike A. Royal 66 2014 Chief Medical Officer

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
12/21/2022 Henry H. Ji
See Remarks; Director
300   1,650
12/15/2022 Henry H. Ji
See Remarks; Director
1,500,000   Award at $0 per share. 0
12/02/2022 Henry H. Ji
See Remarks; Director
200   1,100
09/07/2022 Henry H. Ji
See Remarks; Director
88,888   Acquisition at $2.02 per share. 179,553
09/06/2022 Henry H. Ji
See Remarks; Director
55,555   Acquisition at $1.96 per share. 108,887
09/02/2022 Henry H. Ji
See Remarks; Director
2,500,000   Award at $0 per share. 0
08/26/2022 Henry H. Ji
See Remarks; Director
33,333   Acquisition at $2.11 per share. 70,332
08/25/2022 Henry H. Ji
See Remarks; Director
22,222   Acquisition at $2.06 per share. 45,777
06/14/2022 Henry H. Ji
See Remarks; Director
10,000   Acquisition at $1.4 per share. 14,000
12/27/2021 Kim D. Janda
Director
3,000   Disposition at $5.88 per share. 17,640
12/27/2021 Kim D. Janda
Director
3,000   Derivative/Non-derivative trans. at $4 per share. 12,000
/news/latest/company/us/srne

MarketWatch News on SRNE

  1. Biotech Stocks Are Up by Double Digits. It's Still a Bear Market.

    7:48 a.m. July 25, 2022

    - Barron's Online

  2. Sorrento Therapeutics says initial testing showed its COVISTIX test demonstrated ability to detect omicron variant

    9:25 a.m. Dec. 27, 2021

    - Tomi Kilgore

  3. Sorrento Therapeutics started at buy with $26 stock price target at B. Riley

    7:46 a.m. Jan. 29, 2021

    - Tomi Kilgore

  4. Charting market rotation, S&P 500 presses record territory

    12:40 p.m. Jan. 26, 2021

    - Michael Ashbaugh

  5. Charting market rotation, S&P 500 presses record territory

    12:16 p.m. Jan. 26, 2021

    - Michael Ashbaugh

  6. Sorrento stock falls after company fires CFO

    4:57 p.m. Aug. 18, 2020

    - Wallace Witkowski

  7. Sorrento Therapeutics started at buy with $24 stock price target at Dawson James Securities

    6:30 a.m. May 26, 2020

    - Tomi Kilgore

  8. America’s New Pastime: Day Trading

    8:40 a.m. May 23, 2020

    - Barron's Online

  9. Sorrento stock's intraday high of $10 was nearly 4 times Thursday's closing price

    1:39 p.m. May 18, 2020

    - Tomi Kilgore

  10. Sorrento Therapeutics' stock gains 1.9%, but pares earlier surge of as much as 48%

    1:38 p.m. May 18, 2020

    - Tomi Kilgore

  11. Stocks Rise Because There Is ‘No Limit’ to What Fed Can Do

    6:48 a.m. May 18, 2020

    - Barron's Online

  12. Sorrento Therapeutics' stock soars 44% premarket, after rocketing 158% on Friday

    6:30 a.m. May 18, 2020

    - Tomi Kilgore

  13. Loading more headlines...
/news/nonmarketwatch/company/us/srne

Other News on SRNE

  1. 10-Q: SORRENTO THERAPEUTICS, INC.

    4:34 p.m. Nov. 8, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  2. Sorrento Therapeutics: Down The Rabbit Hole

    11:34 p.m. Nov. 7, 2022

    - Seeking Alpha

  3. Sorrento in credit agreement with B. Riley for $41.7M

    2:36 p.m. Sept. 30, 2022

    - Seeking Alpha

  4. Why Sorrento Therapeutics Stock Is Marching Higher Today

    11:01 a.m. Aug. 31, 2022

    - Motley Fool

  5. 2 Penny Stocks That Could Make You Filthy Rich

    8:45 a.m. Aug. 24, 2022

    - Motley Fool

  6. Why Sorrento Therapeutics Stock Is Popping Today

    2:08 p.m. Aug. 23, 2022

    - Motley Fool

  7. Sorrento Therapeutics: COVISTIX Sales Are Lagging Behind

    1:21 a.m. Aug. 20, 2022

    - Seeking Alpha

  8. Loading more headlines...

At a Glance

Sorrento Therapeutics, Inc.

4955 Directors Place

San Diego, California 92121

Phone

1 8582034100

Industry

Biotechnology

Sector

Health Care/Life Sciences

Fiscal Year-end

12/2022

Revenue

$52.90M

Net Income

$-428.33M

Employees

799.00

/news/pressrelease/company/us/srne

Press Releases on SRNE

  1. Why is Sorrento Therapeutics (SRNE Stock) Rising Today?

    10:34 a.m. Oct. 21, 2022

    - PressReach.com

  2. Why Did SRNE Stock Drop 23.4% in September?

    1:18 p.m. Oct. 5, 2022

    - PressReach.com

  3. Sorrento Stock Price Down 5.3%

    10:30 a.m. Sept. 22, 2022

    - PressReach.com

  4. Loading more headlines...
Link to MarketWatch's Slice.